ANTIBIOTIC DOSE AND DOSE INTERVALS IN RRT and ECMO

Similar documents
Practical issues - dosing on extracorporeal circuits

CRRT and Drug dosing. Karlee Johnston Lead Pharmacist Division of Critical Care ICU Education June 2017

Is the package insert correct? PK considerations

Continuous Renal Replacement Therapy. Gregory M. Susla, Pharm.D., F.C.C.M. Associate Director, Medical Information MedImmune, LLC Gaithersburg, MD

AUGMENTED RENAL CLEARANCE and its clinical implications. Professor Jeffrey Lipman

Continuous Renal Replacement Therapy

- SLED Sustained Low-Efficiency Dialysis

PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS

Should we be performing TDM in seriously ill patients with Gram negative infections?

UNDERSTANDING THE CRRT MACHINE

Drug dosing in patients with acute kidney injury

Medication Dosing in CRRT

Drug Management in CRRT

Lessons from recent studies. João Gonçalves Pereira UCIP DALI

Managing Acid Base and Electrolyte Disturbances with RRT

Physiology of Blood Purification: Dialysis & Apheresis. Outline. Solute Removal Mechanisms in RRT

ECMO & Renal Failure Epidemeology Renal failure & effect on out come

Drug Use in Dialysis

Renal Replacement Therapy in ICU. Dr. Sunil Sharma Senior Resident Dept of Pulmonary Medicine

CRRT Fundamentals Pre- and Post- Test. AKI & CRRT Conference 2018

ICU Volume 11 - Issue 3 - Autumn Series

Continuous renal replacement therapy. David Connor

Pharmacokinetics pharmacodynamics issues relevant for the clinical use of betalactam antibiotics in critically ill patients

RENAL FAILURE IN ICU. Jo-Ann Vosloo Department Critical Care SBAH

Pediatric Continuous Renal Replacement Therapy

Continuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook

Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Pharmacy Faculty, Siam University, Bangkok, Thailand

Renal Physiology Intro to CRRT Concepts. Catherine Jones September 2017

MODALITIES of Renal Replacement Therapy in AKI

The general Concepts of Pharmacokinetics

egfr 34 ml/min egfr 130 ml/min Am J Kidney Dis 2002;39(suppl 1):S17-S31

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

CRRT: The Technical Questions Modality & Dose. Ashita J. Tolwani, MD, MSc University of Alabama at Birmingham 2018

Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement

Dialysis Dose Prescription and Delivery. William Clark, M.D. Claudio Ronco, M.D. Rolando Claure-Del Granado, M.D. CRRT Conference February 15, 2012

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Recent advances in CRRT

PHA Spring First Exam. 8 Aminoglycosides (5 points)

SHC Vancomycin Dosing Guide

CRRT for the Experience User 1. Claudio Ronco, M.D. David Selewski, M.D. Rolando Claure-Del Granado, M.D. AKI & CRRT Conference March, 2018

Karen Mak R.N. (Team Leader) Renal Dialysis Centre Hong Kong Sanatorium & Hospital

Title. Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): Issue Date Doc URL. Rights.

Drug Dosing in Renal Insufficiency. Coralie Therese D. Dimacali, MD College of Medicine University of the Philippines Manila

La farmacologia in aiuto

ZIN EN ONZIN VAN ANTIBIOTICASPIEGELS BIJ NEONATEN

Can We Achieve Precision Solute Control with CRRT?

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale

TDM of Aminoglycoside Antibiotics

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Antibiotic Dosing in Critically Ill Patients. Receiving Prolonged Intermittent. Renal Replacement Therapy

Renal replacement therapy in acute kidney injury

prophylaxis for endocarditis in patients at high risk prophylaxis for major surgical procedures

CRRT Fundamentals Pre- and Post- Test Answers. AKI & CRRT 2017 Practice Based Learning in CRRT

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Uncommon Indications for Extracorporeal Toxin Removal (ECTR) Robert S. Hoffman, MD Director, Division of Medical Toxicology NYU School of Medicine

UAB CRRT Primer Ashita Tolwani, MD, MSc University of Alabama at Birmingham

Acute Kidney Injury- What Is It and How Do I Treat It?

Renal replacement therapy in Pediatric Acute Kidney Injury

PK/PD degli antibiotici utilizzati nella sepsi

Continuous Renal Replacement Therapy in PICU: explanation/definitions/rationale/background

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

CRRT. ICU Fellowship Training Radboudumc

EXTRACORPOREAL TECHNIQUES IN MODS: An Update :Techniques For Organ Support Where Are We In 2013? Prof Patrick Honoré,MD, PhD, Intensivist-Nephrologist

Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis

Commentary Recent evolution of renal replacement therapy in the critically ill patient Claudio Ronco

PD In Acute Kidney Injury. February 7 th -9 th, 2013

Vancomycin: Class: Antibiotic.

Aquarius Study Day Adult Pre-Reading Study Pack

Continuous Renal Replacement Therapy Based Dose Adjustments - Adult - Inpatient Clinical Practice Guideline

AMINOGLYCOSIDES TDM D O N E B Y

Therapeutic drug monitoring of β-lactams

PICANet Custom Audit Definitions Renal Dataset

ASN Board Review: Acute Renal Replacement Therapies

Decision making in acute dialysis

Pharmacodynamic indices in targeting therapy of critical infections

Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Optimizing antifungal dosing regimens. Joseph Meletiadis, PhD, FECMM Assistant Professor of Microbiology

PICANet Renal Dataset supplement Renal Daily Interventions

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

7/17/2017 FSHP 2017 ANNUAL MEETING. Medication Considerations for the Adult/Pediatric ICU Patient Receiving Renal Replacement Therapy

PICANet Custom Audit Definitions Renal Dataset

Can We Achieve Precision Solute Control with CRRT?

Basic Concepts of TDM

The Physiology of Peritoneal Dialysis As Related To Drug Removal

PHA 5128 Final Exam Spring 2004 Version A. On my honor, I have neither given nor received unauthorized aid in doing this assignment.

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018

Disclosures. Efficacy of the drug. Optimizing Dosing Based on PKPD- An overview. Dose Finding - The Past

New method of blood purification (Recycle Filtration System)

Who? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011

Cystatin C: A New Approach to Improve Medication Dosing

Continuous renal replacement therapy Gulzar Salman Amlani Aga Khan University, School of Nursing, Karachi.

higher dose with progress in technical equipment. Continuous Dialysis: Dose and Antikoagulation. prescribed and delivered

Comparing Methods for Once Daily Tobramycin Exposure Predictions in Children with Cystic Fibrosis

Nurse-Pharmacist Collaboration in the Delivery of Continuous Renal Replacement Therapy

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA5128 Dose Optimization II Case Study 3 Spring 2013

Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2

Technical aspects of RRT in AKI: access, anticoagulation, drug dosage and nutrition. Marlies Ostermann

Transcription:

ANTIBIOTIC DOSE AND DOSE INTERVALS IN RRT and ECMO Professor Jeffrey Lipman Department of Intensive Care Medicine Royal Brisbane Hospital University of Queensland

NO CONFLICT OF INTERESTS

Important concept Recommended dosages are obtained from healthy volunteers and possibly (ward) sick patients

Clinical pharmacology: drug development Antibiotic regimens are derived from noncritically ill volunteers. Their haemodynamic system is normal, as is their liver and kidney blood flow. They have not leaky capillaries nor have they drips and pipes in every orifice.

The kidney and antibiotics Blot S et al. Diagnostic Microbiology and Infectious Disease 2014;79:77 84

Antibiotic related IMPORTANT pharmacokinetic parameters Cmax Peak Concentration Cmin t 1/2 V AUC Cl Trough Concentration Half-life (or V D ) Volume of distribution Area under curve Clearance Protein binding

Capillary lead and fluid administration

Marik PE Anaesthesia and Intensive Care 1993;21:172-3.

.we have found that higher-thanrecommended loading and daily doses of vancomycin seem to be necessary to rapidly achieve therapeutic serum concentrations. 35mg/kg loading 35mg/kg/day

VOLUME OF DISTRIBUTION ALTERATIONS IN ICU Antibiotics that stay in extravascular and extracellular space ie that don t penetrate solid organs, (hydrophilic tendencies) namely AMINOGLYCOSIDES GLYCOPEPTIDES β-lactams (to a lesser extent) COLISTIN

LOADING DOSE vs CLEARANCES Fundamental concept Loading dose is INDEPENDENT of clearances EVEN IN RENAL FAILURE (without clearance) YOU MUST GIVE LOADING DOSE

LOW EXPOSURE TO ANTIBIOTICS ENABLES DEVELOPMENT OF RESISTANCE Critical Care Medicine August 2008;36:2433-40

Sepsis changes PK Extracorporeal circuits Altered CL and Increased Vd cf AKI? Plasma concentrations

(C)RRT (Continuous) Renal Replacement Therapy Kidney Filter FLOW Semi-permeable Membrane FLOW Ultrafiltrate Dialysate

CRRT Effects on Electrolytes and Water.. and Drugs. FLOW K K Ca Ca PO4 H2O Cr Cr Cr Cr Ur Semi-permeable Membrane FLOW Ultrafiltrate +/- Dialysate

DRUG CLEARANCE If you know 1. Membrane Pore Size 2. Drug Size 3. Sieving Coefficient Then it s easy!

DRUG CLEARANCE If you know 1. Membrane Pore Size 2. Drug Size 3. Sieving Coefficient Then it s easy!

CRRT Continuous Renal Replacement Therapy Kidney Filter Access (Pre- Filter) From Patient Return (Post Filter) To Patient FLOW Semi-permeable Membrane FLOW Ultrafiltrate Dialysate

CVVHD Continuous Veno-Venous HeamoDialysis NO Replacement Fluid. Access (Pre- Filter) From Patient FLOW Kidney Filter Return (Post Filter) To Patient Semi-permeable Membrane FLOW Ultrafiltrate Dialysate

CVVHD Removal of urea, toxins, electrolytes & DRUGS (small molecules) FLOW K K Ca Ca PO4 Cr Cr Cr Cr Ur Semi-permeable Membrane FLOW Effluent Dialysate

CVVHD Sd = [Antibiotic] dialysate [Antibiotic] plasma

CVVHD Cl CVVHD Qd x Sd

CVVH Removal of H 2 O, urea, toxins, electrolytes & DRUGS (small + middle molecules) FLOW H2O K K Ca Ca PO4 H2O H2O H2O H2O H2O Cr Cr Cr Cr H2O Ur H2O Semi-permeable Membrane Ultrafiltrate

CVVH Continuous Veno-Venous Heamofiltration Replacement Fluid can be either Pre- Filter or Post Filter. Access (Pre- Filter) From Patient FLOW Kidney Filter Return (Post Filter) To Patient Semi-permeable Membrane FLOW Ultrafiltrate NO Dialysate

CVVH Sc = [Antibiotic] ultrafiltrate [Antibiotic] plasma

CVVH Cl CVVH(pre) = Qf x Sc x CF where CF = Qb Qb + Q pre

CVVHDF Continuous Veno-Venous HeamoDiaFiltration Replacement Fluid can be either Pre- Filter or Post Filter. Access (Pre- Filter) From Patient Kidney Filter Return (Post Filter) To Patient FLOW Semi-permeable Membrane FLOW Ultrafiltrate Dialysate

SLEDD as an alternative And then there is SLEDD Slow Low Efficiency Daily Dialysis, Extended Daily Dialysis A Hybrid of CRRT + IHD Minimal antibiotic clearance data published

Crit Care Med 2011;39:560 70 Nine original research articles plus a few case reports Roberts, Lipman. (Editorial) Crit Care Med 2011;39:602-3

Therapeutic Options of RRT Differ CVVH CVVHD CVVHDF SCUF SLEDD

Tables and equations

If you know 1. Membrane Pore Size 2. Drug Size 3. Sieving Coefficient Then it s easy!

If you know Convection 1. Membrane Pore Size Diffusion 2. Drug Size 3. Sieving Coefficient Protein binding Then Volume of it s distribution easy! Membrane characteristics

HOW DO WE DOSE AT MY HOSPITAL?

Roberts JA, Hope WW, Lipman J. Int J Antimicrob Agents 2010;35:419-20 Roberts JA et al. Int J Antimicrob Agents 2010;36:332-0

BEST WE HAVE Choi et al Crit Care Med 2009;37:2268-82

CRRT and MEROPENEM Jamal et al Crit Care Med 2014:42:1640-50

CRRT and PIPTAZO Jamal et al Crit Care Med 2014:42:1640-50

CRRT and VANC Jamal et al Crit Care Med 2014:42:1640-50

ONE WAY Choi et al Crit Care Med 2009;37:2268-82

Advantages Individualized CRRT MIC Takes PK/PD relationships into account Choi G et al. Crit Care Med 2009; 37: 2268-82 Choi G et al. Blood Purif 2010; 30: 195-212

Alternatively Choose a PK article that most closely resembles the form of CRRT you use Use their clearances see if it seems a reasonable estimate of your clearances Dose accordingly

RECENTLY ACCEPTED REVIEW Jamal JA, Mueller BA, Choi GYS, Lipman J, Roberts JA How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? Diagnostic Microbiology and Infectious Disease

RECENTLY ACCEPTED REVIEW Jamal JA, Mueller BA, Choi GYS, Lipman J, Roberts JA How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy? Diagnostic Microbiology and Infectious Disease TABLE 1: Pharmacokinetic parameters of different class of antibiotics in critically ill patients receiving variable types of renal replacement therapy modalities

IMPORTANT BEDSIDE PRACTICAL POINT.. You may prescribe Continuous RRT. but is it continuous? How often do you come on morning ward round to here the kidney was off for xxx hours? How often do you do rounds to here Oh we are changing the filter Do you factor in for the down time?

IMPORTANT BEDSIDE PRACTICAL POINT.. What do you do when you want to cease RRT. We say leave the filter off for awhile to see if pt passes urine And often forget to change dose of drugs.. Do you factor in for the down time?

CRITICAL CARE Conclusions: This matched cohort study confirms an increase in Vd and a decrease in CL for meropenem in adult patients receiving ECMO. In patients receiving meropenem on ECMO, standard dosing does not always result in optimal drug concentrations because of the significant PK changes in the setting of critical illness, ECMO and RRT. Therapeutic drug monitoring where possible is recommended until robust dosing guidelines become available. Therapeutic drug monitoring

DEFINITION Therapeutic Drug Monitoring (TDM) refers to analysis and subsequent interpretation of drug concentrations in biological fluids

PLACE TDM should be used to maximise efficacy minimize toxicity To personalise dosing for high probability of therapeutic success, prevent development of resistance, provide low probability of toxicity

BETA-LACTAMS Safe drugs Large therapeutic range TDM should be used to maximise efficacy minimize toxicity

J Chromatogr B 2010;878:2039-2043

CONCLUSION For various reasons therapeutic drug monitoring (TDM) of most antibiotics is difficult if not impossible. We have set up a TDM service for all our beta-lactam use and have (not surprisingly ) shown that in more than half of our ICU patients we are dose adjusting once receiving back a drug level!

THE END! j.lipman@uq.edu.au www.som.uq.edu.au/btccrc

ONE WAY Choi et al Crit Care Med 2009;37:2268-82

Loading dose=desired concentration x Vd Calculate CRRT clearance based on mode of CRRT, formulae & published values Total clearance (Cl tot ) =calculated CRRT clearance+non-crrt clearance Time above threshold concentration Pharmacokinetic target? C max :MIC ratio C max :MIC & AUC 24 :MIC Calculate elimination rate = concentration x Cl tot Calculate half-life = 0.693 x Vd / Cl tot Calculate target mean concentration = target AUC 24 /24 Maintenance infusion rate= elimination rate Calculate time to reach target trough concentration Repeat loading dose at calculated time Calculate dosing interval = Dose/(Cp x Cl tot ) Repeat loading dose at calculated dosing interval

Loading dose=desired concentration x Vd Loading dose=desired concentration x Vd (28 l) Desired concentration = 5 x MIC = 20 mg/l Calculate CRRT clearance based on mode of CRRT, formulae & published values Loading dose = 20 x 28 500 mg Total clearance (Cl tot ) =calculated CRRT clearance+non-crrt clearance Time above threshold concentration Pharmacokinetic target? C max :MIC ratio C max :MIC & AUC 24 :MIC Calculate elimination rate = concentration x Cl tot Calculate half-life = 0.693 x Vd / Cl tot Calculate target mean concentration = target AUC 24 /24 Maintenance infusion rate= elimination rate Calculate time to reach target trough concentration Repeat loading dose at calculated time Calculate dosing interval = Dose/(Cp x Cl tot ) Repeat loading dose at calculated dosing interval

Loading dose=desired concentration x Vd Calculate CRRT clearance based on mode of CRRT & published Sc or Sd values Cl CVVH (post) = Qf x Sc = 2450 x 0.95 = 2327 ml/h = 39 ml/min Calculate CRRT clearance based on mode of CRRT, formulae & published values Total clearance (Cl tot ) =calculated CRRT clearance+non-crrt clearance Time above threshold concentration Pharmacokinetic target? C max :MIC ratio C max :MIC & AUC 24 :MIC Calculate elimination rate = concentration x Cl tot Calculate half-life = 0.693 x Vd / Cl tot Calculate target mean concentration = target AUC 24 /24 Maintenance infusion rate= elimination rate Calculate time to reach target trough concentration Repeat loading dose at calculated time Calculate dosing interval = Dose/(Cp x Cl tot ) Repeat loading dose at calculated dosing interval

Loading dose=desired concentration x Vd Calculate CRRT clearance based on mode of CRRT, formulae & published values Total clearance Total clearance (Cl tot (Cl ) =calculated tot ) CRRT clearance+non-crrt clearance clearance = 39 + 60 100 ml/min = 0.1 l/min Time above threshold concentration Pharmacokinetic target? C max :MIC ratio C max :MIC & AUC 24 :MIC Calculate elimination rate = concentration x Cl tot Calculate half-life = 0.693 x Vd / Cl tot Calculate target mean concentration = target AUC 24 /24 Maintenance infusion rate= elimination rate Calculate time to reach target trough concentration Repeat loading dose at calculated time Calculate dosing interval = Dose/(Cp x Cl tot ) Repeat loading dose at calculated dosing interval

Loading dose=desired concentration x Vd Calculate CRRT clearance based on mode of CRRT, formulae & published values Total clearance (Cl tot ) =calculated CRRT clearance+non-crrt clearance Time above threshold concentration Calculate elimination rate Pharmacokinetic target? C max :MIC ratio C max :MIC & AUC 24 :MIC = concentration x Cl tot = 20 x 0.1 = 2 mg/min Calculate elimination rate = concentration x Cl tot Calculate half-life = 0.693 x Vd / Cl tot Calculate target mean concentration = target AUC 24 /24 Maintenance infusion rate= elimination rate Calculate time to reach target trough concentration Repeat loading dose at calculated time Calculate dosing interval = Dose/(Cp x Cl tot ) Repeat loading dose at calculated dosing interval

Loading dose=desired concentration x Vd Calculate CRRT clearance based on mode of CRRT, formulae & published values Total clearance (Cl tot ) =calculated CRRT clearance+non-crrt clearance Time above threshold concentration Pharmacokinetic target? C max :MIC ratio C max :MIC & AUC 24 :MIC Calculate elimination rate = concentration x Cl tot Calculate half-life = 0.693 x Vd / Cl tot Calculate target mean concentration = target AUC 24 /24 Maintenance infusion rate = elimination rate = 2 mg/min Maintenance infusion rate= elimination rate Calculate time to reach target trough concentration Repeat loading dose at calculated time Calculate dosing interval = Dose/(Cp x Cl tot ) Repeat loading dose at calculated dosing interval